BF Biosciences Limited, a Pakistani pharmaceutical company, has announced a change at the top, with founding Chief Executive Officer (CEO) Akhter Khalid Waheed set to step down on December 31, 2025, ...
In a major boost to Pakistan’s pharmaceutical sector, BF Biosciences Limited has introduced Zeptide (Tirzepatide), an advanced dual-action therapy for Type 2 diabetes and obesity, developed and ...
Pakistan has launched its first biopharma company BF Biosciences based in Lahore, to manufacture interferon-a for hepatitis treatment. BF Biosciences is a joint venture between Pakistan's largest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback